Off-label paediatric drug use in an Indonesian community setting

被引:4
作者
Abdulah, R. [1 ]
Khairinisa, M. A. [1 ]
Pratiwi, A. A. [1 ]
Barliana, M. I. [2 ]
Pradipta, I. S. [1 ]
Halimah, E. [1 ]
Diantini, A. [1 ]
Lestari, K. [1 ]
机构
[1] Padjadjaran State Univ, Fac Pharm, Dept Pharmacol & Clin Pharm, Jatinangor 45363, Indonesia
[2] Padjadjaran State Univ, Dept Biol Pharm, Fac Pharm, Jatinangor 45363, Indonesia
关键词
drug safety; off-label prescribing; paediatrics; MEDICINE USE; CHILDREN; INPATIENTS; WARDS;
D O I
10.1111/jcpt.12276
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objectiveOff-label medication is often used in the treatment of paediatric patients. However, it should be restricted due to the lack of evidence related to its efficacy and safety. Little is known about the frequency of off-label drug use or the degree of scientific evidence supporting this practice in Indonesia. The aim of this study was to investigate the off-label prescribing practice for paediatric patients in Bandung city, Indonesia. MethodsWe conducted a retrospective and population-based study including 4936 prescriptions written by paediatricians for 0- to 5-year-old patients from 14 selected community pharmacies in 2012 and analysed the off-label uses. Results and discussionOf the total prescriptions, 18.6% contained at least one off-label drug. Furthermore, 7% of the 16516 prescribed drugs were categorized as off-label. Of all of the prescribed drugs, doxycycline and domperidone were the most prescribed drugs with off-label indications. What is new and conclusionThis is the first study that shows a significant number of off-label drugs prescribed for children in Indonesia; therefore, efforts should be made to scrutinize under-evaluated off-label prescribing practices that may compromise patient safety.
引用
收藏
页码:409 / 412
页数:4
相关论文
共 34 条
[11]   Off licence and off label prescribing in children: litigation fears for physicians [J].
Hill, P .
ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 :I17-I18
[12]   Off-label drug use among hospitalised children:: identifying areas with the highest need for research [J].
Hsien, Linda ;
Breddemann, Andre ;
Frobel, Anne-Kristina ;
Heusch, Andreas ;
Schmidt, Klaus G. ;
Laeer, Stephanie .
PHARMACY WORLD & SCIENCE, 2008, 30 (05) :497-502
[13]   The problems in scaling adult drug doses to children [J].
Johnson, T. N. .
ARCHIVES OF DISEASE IN CHILDHOOD, 2008, 93 (03) :207-211
[14]   Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints [J].
Kesselheim, Aaron S. ;
Mello, Michelle M. ;
Studdert, David M. .
PLOS MEDICINE, 2011, 8 (04) :13
[15]   Off-Label Drug Use in Pediatric Patients [J].
Kimland, E. ;
Odlind, V. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) :796-801
[16]   Off-label medicine use in children and adolescents: results of a population-based study in Germany [J].
Knopf, Hildtraud ;
Wolf, Ingrid-Katharina ;
Sarganas, Giselle ;
Zhuang, Wanli ;
Rascher, Wolfgang ;
Neubert, Antje .
BMC PUBLIC HEALTH, 2013, 13
[17]  
Lacy C. F., 2012, DRUG INFORM HDB COMP
[18]   Incidence of unlicensed and off-label prescription in children [J].
Langerova, Petra ;
Vrtal, Jiri ;
Urbanek, Karel .
ITALIAN JOURNAL OF PEDIATRICS, 2014, 40
[19]   Off-label medication use in adult critical care patients [J].
Lat, Ishaq ;
Micek, Scott ;
Janzen, Jeffrey ;
Cohen, Henry ;
Olsen, Keith ;
Haas, Curtis .
JOURNAL OF CRITICAL CARE, 2011, 26 (01) :89-94
[20]   Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature [J].
Lindell-Osuagwu, L. ;
Korhonen, M. J. ;
Saano, S. ;
Helin-Tanninen, M. ;
Naaranlahti, T. ;
Kokki, H. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (03) :277-287